Conference Coverage

Nurses’ health studies show no link between diet, multiple sclerosis


 

AT MSBOSTON 2014

References

BOSTON – Diet does not appear to contribute to the development of multiple sclerosis, according to findings from more than 185,000 prospectively followed women from the Nurses’ Health Study and the Nurses’ Health Study II.

None of three dietary indices measured at baseline – the Alternative Healthy Eating Index-2010 (AHEI-2010), the Alternate Mediterranean Diet index (aMED), and the Dietary Approaches to Stop Hypertension index (DASH) – were significantly associated with the risk of developing multiple sclerosis in the two longitudinal cohort studies, Dr. Dalia Rotstein reported at the a joint meeting of the European and Americas Committees for Treatment and Research in Multiple Sclerosis.

Diet does not contribute to the development of multiple sclerosis, says a new study. © Dušan Zidar / Fotolia.com

Diet does not contribute to the development of multiple sclerosis, says a new study.

After adjustment for known confounders of multiple sclerosis (MS) risk, including age, latitude of residence at age 15 years, body mass index at age 18 years, pack-years of smoking, total energy intake, supplemental vitamin D intake, and ethnicity, the pooled relative risk of MS for the highest vs. the lowest quintile of scores for each index was 0.89 for the AHEI-2010, 1.10 for aMED, and 1.30 for DASH, said Dr. Rotstein of Brigham and Women’s Hospital, Boston.

A principal-components analysis identified two general dietary patterns among the subjects. One was a “Western” dietary pattern with high intake of red and processed meats, refined grains, and sweets, and the other was a “prudent” dietary pattern with high intake of vegetables, fruit, legumes, fish, poultry, and whole grains. Neither was associated with MS risk (relative risk for the highest vs. lowest quintile of scores, 0.71 and 1.09, respectively).

The results were similar when looking at mean cumulative dietary scores and when looking at the two cohorts separately, she said.

An exception in the analysis using mean cumulative dietary score was for the Western dietary pattern, which was shown to have a significant inverse association with MS risk (relative risk, 0.66). “This just met statistical significance, and we believe that this result is an artifact,” Dr. Rotstein said.

Study participants completed semiquantitative food frequency questionnaires every 4 years, beginning in 1984 for the Nurses’ Health Study (NHS) and in 1991 for NHS II. The MS cases were documented as of 2004 for NHS (130 cases) and as of 2009 for NHS II (350 cases).

With the exception of studies on vitamin D intake, prior studies have yielded null or inconsistent results with respect to the role of diet in MS development, and most have been limited by a focus on individual dietary elements and by small sample size.

The current study is the first large, prospective, population-based study to investigate the relationship, and it shows no evidence of an association between overall dietary quality and MS, she said.

The study is limited by the inherent subjectivity in dietary scores and by a basis in population norms rather than ideal consumption patterns. Also, the study is conceived around recommendations for cardiovascular health, but other dietary patterns may be more relevant for immunological health, she said, noting that additional study is needed to determine if dietary quality and individual dietary elements in the early years play a role in MS development.

Dr. Rotstein reported having no disclosures.

Recommended Reading

VIDEO: Predicting time to relapse after CIS in largest-ever study of high-risk patients
MDedge Neurology
Alemtuzumab safety and efficacy persist at 4 years in relapsing-remitting multiple sclerosis
MDedge Neurology
Factors may identify high-risk patients with clinically isolated syndrome
MDedge Neurology
Automating and Improving the EDSS—Validation of the eEDSS
MDedge Neurology
Alasdair Coles, MD
MDedge Neurology
Letizia Leocani, MD, PhD
MDedge Neurology
Phase II RADIANCE study results demonstrate efficacy of RPC1036 in MS
MDedge Neurology
Interferon beta-1a, glatiramer acetate prove cost effective for long-term MS treatment
MDedge Neurology
VIDEO: Novel sphingosine 1-phosphate 1 receptor modulator has promising safety results
MDedge Neurology
Trial probes mechanism of THC-CBD improvement of multiple sclerosis spasticity
MDedge Neurology